Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.654,77
0,26%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Acer Therapeutics Com USD0.01 (OPXA) Acer Therapeutics Com USD0.01 (OPXA) Notizie

OPXA

Acer Therapeutics Com USD0.01 (OPXA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPXA
DataOraFonteTitoloSimboloCompagnia
06/10/201722:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPXAAcer Therapeutics Com USD0.01
06/10/201722:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPXAAcer Therapeutics Com USD0.01
05/10/201714:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPXAAcer Therapeutics Com USD0.01
29/09/201722:51Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OPXAAcer Therapeutics Com USD0.01
01/09/201713:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPXAAcer Therapeutics Com USD0.01
14/08/201713:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPXAAcer Therapeutics Com USD0.01
11/08/201712:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPXAAcer Therapeutics Com USD0.01
11/08/201712:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OPXAAcer Therapeutics Com USD0.01
08/08/201723:17Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OPXAAcer Therapeutics Com USD0.01
04/08/201722:10Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OPXAAcer Therapeutics Com USD0.01
19/07/201723:26Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OPXAAcer Therapeutics Com USD0.01
03/07/201712:13Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPXAAcer Therapeutics Com USD0.01
28/03/201722:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OPXAAcer Therapeutics Com USD0.01
08/12/201618:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPXAAcer Therapeutics Com USD0.01
11/08/201623:20Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OPXAAcer Therapeutics Com USD0.01
11/04/201612:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPXAAcer Therapeutics Com USD0.01
25/03/201621:27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPXAAcer Therapeutics Com USD0.01
24/03/201605:37InvestorsHub NewsWireOPEXA THERAPEUTICS - RESTRUCTURING SHARPENS FOCUS ON TCELNA DATANASDAQ:OPXAAcer Therapeutics Com USD0.01
18/03/201621:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:OPXAAcer Therapeutics Com USD0.01
05/02/201622:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPXAAcer Therapeutics Com USD0.01
17/11/201514:00Business WireOpexa Therapeutics Chosen as One of the Top Autoimmune Therapy Projects to WatchNASDAQ:OPXAAcer Therapeutics Com USD0.01
10/11/201522:05Business WireOpexa Therapeutics Announces Supportive Preclinical Study Results for its Neuromyelitis Optica (NMO) ProgramNASDAQ:OPXAAcer Therapeutics Com USD0.01
10/11/201522:01Business WireOpexa Therapeutics Reports Third Quarter 2015 Financial Results and Provides Corporate UpdateNASDAQ:OPXAAcer Therapeutics Com USD0.01
06/11/201514:30Business WireOpexa Therapeutics Announces News Release Schedule for Third Quarter 2015 Financial ResultsNASDAQ:OPXAAcer Therapeutics Com USD0.01
19/10/201514:11Business WireOpexa Therapeutics to Host Analyst and Investor Event on November 10 in New YorkNASDAQ:OPXAAcer Therapeutics Com USD0.01
15/10/201514:00Business WireOpexa Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Listing RequirementNASDAQ:OPXAAcer Therapeutics Com USD0.01
13/10/201513:00Business WireOpexa Therapeutics to Present at BIO Investor ForumNASDAQ:OPXAAcer Therapeutics Com USD0.01
06/10/201513:00Business WireOpexa Announces Granting of New T-cell Patents Covering Tcelna®; Patent Estate Increases to 160 Issued PatentsNASDAQ:OPXAAcer Therapeutics Com USD0.01
28/09/201513:00Business WireOpexa Announces Reverse Stock SplitNASDAQ:OPXAAcer Therapeutics Com USD0.01
01/09/201512:00Business WireOpexa Secures Private Funding for its NMO Orphan Development Program, Including Planned Phase I/II Clinical StudyNASDAQ:OPXAAcer Therapeutics Com USD0.01
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPXA

La tua Cronologia

BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TITR
Telecom Italia
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
PIRC
Pirelli & C
BIT
SPM
Saipem
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network